If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...

A v rben kering feh rv rsejtek sz m nak k ros cs kken se. Sz mos oka lehet, gyakoriak a vegyszer rtalmak s a gy gyszermell khat sok.

Description as described by BassPro Packed with features of higher priced kayaks, the Ascend® D10T Sit-On-Top Kayak delivers great performance out on the wat…

OncologyPRO is the home of ESMOs educational & scientific resources, with exclusive content for ESMO members such as ESMOs Congresses webcasts,

TY - JOUR. T1 - Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas. AU - Zeidan, Youssef H.. AU - Shultz, David B.. AU - Murphy, James D.. AU - An, Yi. AU - Chan, Cato. AU - Kaplan, Michael J.. AU - Colevas, A. Dimitrios. AU - Kong, Christina. AU - Chang, Daniel T.. AU - Le, Quynh Thu. PY - 2013/11/1. Y1 - 2013/11/1. N2 - Objectives/Hypothesis Postoperative radiation therapy is often used in patients with high-risk salivary gland carcinomas. In this study we evaluated the outcomes and prognostic factors in patients with minor salivary gland cancers treated with adjuvant radiation therapy. Study Design Retrospective cohort study. Methods We performed a retrospective analysis of 90 patients treated with curative intent. Median follow-up was 71 months. Fifty-eight patients (64%) had adenoid cystic carcinomas, 22 (24%) had adenocarcinomas, and 10 (11%) had mucoepidermoid cancers. Primary disease site included 39 (43%) sinonasal, 35 (39%) oral cavity, 10 ...

Symptoms of Mucoepidermoid including 8 medical symptoms and signs of Mucoepidermoid, alternative diagnoses, misdiagnosis, and correct diagnosis for Mucoepidermoid signs or Mucoepidermoid symptoms.

This is a single agent, prospective, open-label, monocenter, phase II trial of sorafenib in patients with recurrent and/or metastatic salivary gland carcinoma. This trial will be conducted with the primary aim to determine the response rate (CR+PR) according to the RECIST criteria. Response rate according to CHOI criteria, correlation between CHOI criteria and outcome, disease Control Rate (DCR) and acute toxicity will be evaluated as secondary objectives ...

A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.

Immunostaining for p63, p504S and the androgen receptor status are important markers for carcinomas of the prostate. The purpose of this study was to investigate the staining characteristics of these markers for malignancies of salivary gland origin. Wax blocks of 32 malignant salivary gland neoplasms were retrieved, sections prepared and stained by the H&E method and immunoperoxidase techniques for the demonstration of p63 (Dako N1604), p504S (Dako N1609) and androgen receptors (Dako M3562). The sections were viewed by light microscopy and positivity scored with the aid of a grading scale. Androgen receptor- and p504S positivity were infrequently observed in the study samples, except for salivary duct carcinoma and mucoepidermoid carcinoma where most of the cases stained positive for p504S. The staining pattern of adenoid cystic carcinomas for p63 correlated with the microscopic subtype. The basal- and intermediate cells of mucoepidermoid carcinomas stained positive- and the mucus- and epidermoid